Bettina Franz

Title: Bettina Franz: Innovator in Therapeutic Peptides

Introduction

Bettina Franz is a prominent inventor based in Orem, Utah, known for her significant contributions to the field of therapeutic peptides. With a total of five patents to her name, she has made remarkable strides in cancer treatment methodologies.

Latest Patents

Her latest patents focus on compositions comprising peptides that immunospecifically bind to defined binding partners, such as MHC class I polypeptide-related sequence A (MICA). These innovative peptides include complementarity determining regions that are crucial for their function. The patents also detail methods for treating cancer in subjects using these compositions, as well as techniques for isolating human antibodies from cancer patients following immunotherapy.

Career Highlights

Bettina has worked with esteemed organizations such as the Dana-Farber Cancer Institute and Kymab Limited. Her work in these institutions has allowed her to advance her research and contribute to the development of new therapeutic strategies.

Collaborations

Throughout her career, Bettina has collaborated with notable professionals in her field, including Kai W. Wucherpfennig and Kenneth F. May, Jr. These partnerships have further enriched her research and innovation efforts.

Conclusion

Bettina Franz stands out as a leading inventor in the realm of therapeutic peptides, with her work paving the way for new cancer treatment options. Her dedication to innovation continues to impact the medical field positively.